Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01661673 |
|
Recruitment Status :
Completed
First Posted : August 9, 2012
Last Update Posted : January 13, 2014
|
Sponsor:
FORUM Pharmaceuticals Inc
Collaborator:
Parexel
Information provided by (Responsible Party):
FORUM Pharmaceuticals Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | October 2013 |
| Study Completion Date : | No date given |